<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.4-a.3'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//ph-ksp.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://ph-ksp.com/contemporary-economic-hospitalization-and-mortality-burden-among-pulmonary-arterial-hypertension-patients-a-real-world-us-claims-data-analysis-pulmonary-circulation-october-6-2026/</loc>
  <lastmod>2026-10-22T04:38:35Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Contemporary Economic, Hospitalization, and Mortality Burden Among Pulmonary Arterial Hypertension Patients: A Real-World US Claims Data Analysis, Pulmonary Circulation, October 6, 2026</news:title>
   <news:publication_date>2026-10-22T04:38:32Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/gossamer-submits-new-drug-application-to-the-us-food-and-drug-administration-fda-for-seralutinib-in-pulmonary-arterial-hypertension-pah/</loc>
  <lastmod>2026-10-22T04:25:02Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Gossamer submits New Drug Application to the US Food and Drug Administration (FDA) for seralutinib in pulmonary arterial hypertension (PAH)</news:title>
   <news:publication_date>2026-10-22T04:25:01Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/every-breath-counts-the-evolving-role-of-inhaled-therapies-in-pulmonary-arterial-hypertension-pah-and-pulmonary-hypertension-linked-to-interstitial-lung-disease-ph-ild-european-medical-journal/</loc>
  <lastmod>2026-10-22T04:13:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Every Breath Counts: The Evolving Role of Inhaled Therapies in pulmonary arterial hypertension (PAH) and pulmonary hypertension linked to interstitial lung disease (PH-ILD), European Medical Journal, October 20, 2026</news:title>
   <news:publication_date>2026-10-22T04:13:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/estimating-mean-pulmonary-arterial-pressure-mpap-in-the-machine-learning-era-european-respiratory-journal-october-9-2026/</loc>
  <lastmod>2026-10-22T03:55:26Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Estimating mean pulmonary arterial pressure (mPAP) in the machine learning era, European Respiratory Journal, October 9, 2026</news:title>
   <news:publication_date>2026-10-22T03:50:11Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/global-data-on-pulmonary-arterial-hypertension-in-people-aged-60-and-over-reveals-diverging-trajectories-in-rich-and-poor-nations-pulmonary-hypertension-news-october-12-2026/</loc>
  <lastmod>2026-10-22T03:32:32Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Global data on pulmonary arterial hypertension in people aged 60 and over reveals diverging trajectories in rich and poor nations, Pulmonary Hypertension News, October 12, 2026</news:title>
   <news:publication_date>2026-10-22T03:29:53Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>